HLA diversity: Detection and impact on unrelated hematopoietic stem cell · donor characterization and selection
- 1 March 2002
- journal article
- review article
- Published by Springer Nature in International Journal of Hematology
- Vol. 76 (S2) , 152-154
- https://doi.org/10.1007/bf03165107
Abstract
Matching of patient and unrelated donor for HLA molecules significantly decreases the probability of graft rejection, graft vs. host disease, and transplant-related mortality in hematopoietic stem cell transplantation. A significant challenge in the identification of matched donors is the diversity of the HLA system. Almost 1500 alleles have been identified at 12 HLA loci. Significant progress has been made in the application of DNA-based testing to identify this diversity in patients and unrelated volunteer donors; however, the resolution of registry testing remains limited by the need to test many donors inexpensively. Thus, the transplant center must predict which donor might be a match for their patient using incomplete typing information. Design of a typing strategy based on knowledge of allele and haplotype frequencies is critical to speed donor identification. A further challenge is to compare patient HLA assignments to the over 7.7 million volunteer donors on registries carrying both DNA and serologic assignments. The links between alleles and serologic specificities remain unclear in many cases and complicate the design of computer algorithms used to match patients and donors. Finally, since few patients will find donors who are allele matched for all HLA loci, studies are underway to understand which of the HLA loci are most critical to match and to define rules of permissive mismatching to achieve an acceptable outcome.Keywords
This publication has 18 references indexed in Scilit:
- HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantationBlood, 2007
- Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program ExperienceBlood, 2001
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor ageBlood, 2001
- The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigensHuman Immunology, 2001
- The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor–recipient pairsBone Marrow Transplantation, 2000
- Maintaining updated DNA-based HLA assignments in the National Marrow Donor Program Bone Marrow Registry.2000
- A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donorsHuman Immunology, 1999
- Effect of Matching of Class I HLA Alleles on Clinical Outcome after Transplantation of Hematopoietic Stem Cells from an Unrelated DonorNew England Journal of Medicine, 1998
- HLA gene and haplotype frequencies in bone marrow donors worldwide registriesHuman Immunology, 1997
- Population Biology of Antigen Presentation by MHC Class I MoleculesScience, 1996